C. Nicolaides

发表

Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.

M. Dimopoulos, K. Syrigos, I. Boukovinas, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients.

N. Pavlidis, D. Pectasides, D Pectasides, 1996, American journal of clinical oncology.

Gemcitabine versus Gemcitabine–Carboplatin for Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2: A Prospective Randomized Phase II Study of the Hellenic Cooperative Oncology Group

M. Dimopoulos, K. Syrigos, I. Boukovinas, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Effect of letrozole on the lipid profile in postmenopausal women with breast cancer.

M. Elisaf, E. Bairaktari, C. Nicolaides, 2001, European journal of cancer.

An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.

H. Kalofonos, G. Fountzilas, D. Pectasides, 2001, Anticancer research.

Serum soluble interleukin-2 receptors in epithelial ovarian cancer patients

N. Pavlidis, J. Kalef-Ezra, E. Bairaktari, 1995, The International journal of biological markers.

The effects of boron and silver on the oxygen-free conversion of methane over Mo/H-ZSM-5 catalysts

M. Scurrell, C. Nicolaides, A. Carley, 2009 .

Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group study.

N. Pavlidis, G. Fountzilas, P. Kosmidis, 1998, Anticancer research.

The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic property.

G. Fountzilas, M. Elisaf, E. Bairaktari, 1996, Anticancer research.

Are the Effects of Tamoxifen on the Serum Lipid Profile Modified by Apolipoprotein E Phenotypes?

M. Elisaf, E. Bairaktari, N. Pavlidis, 2002, Oncology.

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.

M. Dimopoulos, N. Pavlidis, G. Fountzilas, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Docetaxel and Gemcitabine in Anthracycline-Resistant Advanced Breast Cancer: A Hellenic Cooperative Oncology Group Phase II Study

N. Pavlidis, G. Aravantinos, G. Fountzilas, 2000, Cancer investigation.

Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma.

M. Dimopoulos, N. Pavlidis, T. Economopoulos, 2003, The hematology journal : the official journal of the European Haematology Association.

First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group.

N. Pavlidis, C. Papadimitriou, G. Fountzilas, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Vinblastine and Interferon-Gamma Combination with and without 13-Cis Retinoic Acid for Patients with Advanced Renal Cell Carcinoma

M. Dimopoulos, N. Pavlidis, C. Nicolaides, 2002, Oncology.

Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.

M. Dimopoulos, G. Fountzilas, P. Kosmidis, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Short report First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group

C. Papadimitriou, A. Kalogera‐Fountzila, C. Nicolaides, 2005 .

Treatment of intermediate‐ and high‐grade non‐Hodgkin's lymphoma using CEOP versus CNOP

N. Pavlidis, T. Economopoulos, G. Fountzilas, 2002, European journal of haematology.

Dose-Dense Sequential Adjuvant Chemotherapy with Epirubicin, Paclitaxel and CMF in High-Risk Breast Cancer

N. Pavlidis, G. Aravantinos, C. Papadimitriou, 2001, Oncology.

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group.

M. Dimopoulos, D. Pectasides, C. Nicolaides, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group.

N. Pavlidis, C. Papadimitriou, G. Fountzilas, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Is the combination of 5-fluorouracil and folinic acid effective in advanced gastric carcinoma? Results of a pilot study and review of the literature.

N. Pavlidis, G. Klouvas, C. Nicolaides, 1994, Journal of chemotherapy.

Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer.

M. Dimopoulos, G. Fountzilas, P. Papakostas, 1998, Oncology.

Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index

G. Fountzilas, A. Symeonidis, P. Kosmidis, 1998, Oncology.

Gemcitabine (G) vs gemcitabine-carboplatin (GCB) for patients with advanced non-small cell lung cancer (NSCLC) and PS:2. A prospective randomized phase II study of the Hellenic Co-Operative Oncology Group

I. Boukovinas, H. Kalofonos, D. Pectasides, 2004 .

Dose-Dense Adjuvant Chemotherapy with Epirubicin Monotherapy in Patients with Operable Breast Cancer and ≥10 Positive Axillary Lymph Nodes

N. Pavlidis, G. Aravantinos, G. Fountzilas, 1998, Oncology.

Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study.

H. Kalofonos, G. Fountzilas, P. Kosmidis, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Are the effects of tamoxifen on serum lipid profile modified by apolipoprotein E phenotypes

M. Elisaf, E. Bairaktari, N. Pavlidis, 2001 .

Primary Treatment of Low-grade Non-Hodgkin's Lymphoma with the Combination of Fludarabine and Mitoxantrone: A Phase II Study of the Hellenic Cooperative Oncology Group

M. Dimopoulos, T. Economopoulos, E. Papageorgiou, 2002, Leukemia & lymphoma.

A Phase III Study of 5-Fluorouracil Versus 5-Fluorouracil Plus Interferon Alpha 2b Versus 5-Fluorouracil Plus Leucovorin in Patients With Advanced Colorectal Cancer: A Hellenic Cooperative Oncology Group (HeCOG) Study

M. Dimopoulos, G. Aravantinos, H. Kalofonos, 2002, American journal of clinical oncology.

Soluble Interleukin-2 Receptors in Patients with Advanced Colorectal Carcinoma

J. Kalef-Ezra, E. Bairaktari, C. Nicolaides, 1996, The International journal of biological markers.

Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)

K. Syrigos, G. Fountzilas, P. Kosmidis, 2005 .